By Mylan Pharmaceuticals Inc. | Last revised: 6 January 2005
Spironolactone has been shown to be a tumorigen in chronic toxicity studies in rats (see PRECAUTIONS. section). Spironolactone and hydrochlorothiazide tablets should be used only in those conditions described below. Unnecessary use of this drug…
By Bryant Ranch Prepack | Last revised: 4 April 2005
LUNESTA is indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies. LUNESTA administered at bedtime decreased sleep latency and improved sleep maintenance. The clinical trials performed in support of efficacy…
By Roxane Laboratories, Inc. | Last revised: 27 May 2005
Losartan Potassium and Hydrochlorothiazide Tablets are indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy of hypertension, except when the hypertension is severe enough that the value of…
By UDL Laboratories, Inc. | Last revised: 9 September 2005
Spironolactone has been shown to be a tumorigen in chronic toxicity studies in rats (see PRECAUTIONS. section). Spironolactone and hydrochlorothiazide tablets should be used only in those conditions described below. Unnecessary use of this drug…
By PD-Rx Pharmaceuticals, Inc. | Last revised: 14 September 2005
Cimetidine tablets are indicated in: (1) Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see DOSAGE AND ADMINISTRATION:…